Table 3.
Comparison between participants who did not satisfy the PTSD diagnosis after 6 and 12 weeks and those who did
| 6 weeks follow-up (N=23) |
12 weeks follow-up (N=22) |
|||||
|---|---|---|---|---|---|---|
| PTSD (-) | PTSD (+) | p | PTSD (-) | PTSD (+) | p | |
| N=14 | N=9 | N=15 | N=7 | |||
| Baseline score | ||||||
| CAPS | 40.9 (8) | 51.3 (9.9) | 0.011 | 44.0 (7.56) | 47.57 (14.93) | 0.459 |
| GAF | 53.6 (5.08) | 50.1 (5.53) | 0.131 | 52.5 (2.92) | 50.7 (8.81) | 0.471 |
| PCL-5 | 50.9 (11.93) | 65 (12.9) | 0.014 | 52.9 (11.89) | 62.7 (17.12) | 0.131 |
| PHQ-9 | 14.3 (4.97) | 22.7 (4.95) | 0.001 | 16.3 (5.83) | 20.9 (7.20) | 0.126 |
| Diagnosis of comorbid depression at baseline | 2 (14.3) | 6 (66.7) | 0.023 | 3 (20.0) | 5 (71.4) | 0.052 |
| Treatment expectation | 0.4 (4.62) | 0.4 (2.47) | 0.966 | 0 (4.87) | 0.5 (2.16) | 0.789 |
| Treatment satisfaction | 27.8 (3.38) | 26.9 (3.44) | 0.388 | 28.3 (3.22) | 25.1 (2.79) | 0.036 |
The results at 24 week follow up were not statistically significant. CAPS: Clinician Administered PTSD Scale for DSM-5, PCL-5: PTSD Check List-5, PHQ-9: Patient Health Questionnaire-9, GAF: Global Assessment of Function, PTSD: post-traumatic stress disorder